AstraZeneca Plc has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.
from Latest News https://ift.tt/3dTQeez
from Latest News https://ift.tt/3dTQeez
Comments
Post a Comment